CogState is a global provider of cognitive testing products and services. Established in 1999 and becoming a publicly listed company on the ASX in 2004, CogState is currently one of the fastest growing technology companies in Australia having achieved 981% revenue growth across 3 years. CogState tests use simple but effective technology to detect cognitive change in subjects. The tests begin by taking a baseline measurement from a subject who is then periodically retested in order to detect cognitive change. CogState testing utilises culture-neutral stimuli, which ensures that a wide range of subjects can be tested regardless of their ethnicity, socio-economic background or education. CogState ClinicalTrials is a total service rather than just a product. The provision of cognitive testing software to multinational pharmaceutical companies is backed up by scientific consulting services, 24-hour technical support and end-to-end project management. CogState's unique DataPoint® technology allows its customers to view clinical trial data in real time - something that has been unheard of previously in this market. CogState Research is an academically oriented version of the CogState ClinicalTrials software.